CARDIOVASCULAR EFFECTS OF SINGLE ORAL DOSES OF THE NEW BETA-ADRENOCEPTOR BLOCKING-AGENT BETAXOLOL (SL 75212) IN HEALTHY-VOLUNTEERS

被引:30
作者
CADIGAN, PJ [1 ]
LONDON, DR [1 ]
PENTECOST, BL [1 ]
BIANCHETTI, G [1 ]
GOMENI, R [1 ]
KILBORN, JR [1 ]
MORSELLI, PL [1 ]
机构
[1] SYNTHELAB LERS, DEPT CLIN RES, F-75013 PARIS, FRANCE
关键词
D O I
10.1111/j.1365-2125.1980.tb01082.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:569 / 575
页数:7
相关论文
共 19 条
[1]   PHARMACOLOGICAL EFFECTS AND SERUM LEVELS OF ORALLY ADMINISTERED ALPRENOLOL IN MAN [J].
ABLAD, B ;
HALLGREN, J ;
SOLVELL, L ;
JOHNSSON, G ;
ERVIK, M .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1972, 5 (01) :44-&
[2]   SENSITIVE GAS-CHROMATOGRAPHIC METHOD FOR THE DETERMINATION IN BLOOD AND URINE OF SL-75212 [4-(2-CYCLOPROPYLMETHOXYETHYL)-1-PHENOXY-3-ISOPROPYLAMINOPROPAN-2-OL],A NEW BETA-1 ADRENOCEPTOR BLOCKING-AGENT [J].
BIANCHETTI, G ;
GANANSIA, J ;
MORSELLI, PL .
JOURNAL OF CHROMATOGRAPHY, 1979, 176 (01) :134-139
[3]  
BOUDOT JP, 1979, BRIT J PHARMACOL, V66, pP445
[4]   ASSESSMENT OF BETA-ADRENOCEPTOR BLOCKING-DRUGS IN HYPERTHYROIDISM [J].
CARRUTHERS, SG ;
GHOSAL, A ;
MCDEVITT, DG ;
NELSON, JK ;
SHANKS, RG .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 1 (02) :93-98
[5]  
CARUTHER.SG, 1974, CLIN PHARMACOL THER, V15, P497
[6]   METABOLIC STUDIES IN PATIENTS WITH NADOLOL - ORAL AND INTRAVENOUS ADMINISTRATION [J].
DREYFUSS, J ;
BRANNICK, LJ ;
VUKOVICH, RA ;
SHAW, JM ;
WILLARD, DA .
JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 17 (5-6) :300-307
[7]   ABSORPTION OF BETA-ADRENERGIC-BLOCKING AGENT, NADOLOL, BY MICE, RATS, HAMSTERS, RABBITS, DOGS, MONKEYS, AND MAN - UNUSUAL SPECIES-DIFFERENCE [J].
DREYFUSS, J ;
SHAW, JM ;
ROSS, JJ .
XENOBIOTICA, 1978, 8 (08) :503-508
[8]  
EVANS GH, 1973, CLIN PHARMACOL THER, V14, P494
[10]  
Gibaldi M, 1975, PHARMACOKINETICS